Skip to main content

Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases.

Publication ,  Journal Article
Hughes, FM; Cidlowski, JA
Published in: Cell Death Differ
April 1997

Apoptosis is commonly associated with the catabolism of the genome in the dying cell. The chromatin degradation occurs in essentially two forms: (1) internucleosomal DNA cleavage to generate oligonucleosomal-length fragments (180-200 bp and multiples thereof), and (2) cleavage of higher order chromatin structures to generate approximately 30-50 Kb fragments. To investigate this component of apoptosis and identify the nuclease(s) responsible, we have developed and utilized an in vitro assay that recapitulates the genomic destruction seen during apoptosis in vivo and allows the simultaneous analysis of both forms of DNA degradation from the same sample. Using this assay we evaluated the digestion patterns of several candidate apoptotic nucleases: DNase I, DNase II, and cyclophilin (NUC18) as well as the bacterial enzyme micrococcal nuclease (not thought to be involved in apoptosis). Chromatin degraded by DNase I formed a smear of DNA on conventional static-field agarose gels and approximately amp;30 - 50 Kb DNA fragments on pulsed field gels. In contrast, DNase II, at a physiologically relevant pH, had no effect on the integrity of HeLa chromatin in either analysis. Similar to DNase I, cyclophilin C produced only approximately 30-50 Kb DNA fragments but did not generate internucleosomal fragments. In contrast, micrococcal nuclease generated both oligonucleosomal and approximately 30-50 Kb DNA fragments. Nuclear extracts from glucocorticoid-treated apoptotic thymocytes generated oligonucleosomal DNA fragments and the larger approximately 30-50 Kb DNA fragments, fully recapitulating both types of apoptotic DNA degradation. Previously, differential sensitivity of nucleases to inhibition by Zn2+ was used to argue that two distinct enzymes mediate approximately 30-50 Kb DNA cleavage and internucleosomal DNA degradation. While, the nuclease activity present in thymocyte nuclear extracts was differentially sensitive to inhibition by Zn2+ during short term incubations it was not during prolonged digestions, suggesting that differences in DNA detection are likely to account for previous results. Together our studies show that none of the nucleases commonly associated with apoptosis could fully recapitulate the DNA degradation seen in vivo.

Duke Scholars

Published In

Cell Death Differ

DOI

ISSN

1350-9047

Publication Date

April 1997

Volume

4

Issue

3

Start / End Page

200 / 208

Location

England

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hughes, F. M., & Cidlowski, J. A. (1997). Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases. Cell Death Differ, 4(3), 200–208. https://doi.org/10.1038/sj.cdd.4400221
Hughes, F. M., and J. A. Cidlowski. “Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases.Cell Death Differ 4, no. 3 (April 1997): 200–208. https://doi.org/10.1038/sj.cdd.4400221.
Hughes FM, Cidlowski JA. Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases. Cell Death Differ. 1997 Apr;4(3):200–8.
Hughes, F. M., and J. A. Cidlowski. “Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases.Cell Death Differ, vol. 4, no. 3, Apr. 1997, pp. 200–08. Pubmed, doi:10.1038/sj.cdd.4400221.
Hughes FM, Cidlowski JA. Utilization of an in vitro assay to evaluate chromatin degradation by candidate apoptotic nucleases. Cell Death Differ. 1997 Apr;4(3):200–208.

Published In

Cell Death Differ

DOI

ISSN

1350-9047

Publication Date

April 1997

Volume

4

Issue

3

Start / End Page

200 / 208

Location

England

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
  • 06 Biological Sciences